Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
Product Reset all filters
01 1Haemophilia
Recombinant Human Coagulation Factor VIIa
Novo Nordisk
Main Therapeutic Indication : Blood Disorders
Currency : USD
2017 Revenue in Millions : 1,780
2016 Revenue in Millions : 1,780
Growth (%) : 0
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF